Is it effective to take targeted drugs after draining lung cancer in the late stage? How long is it effective?
For patients with late-stage lung cancer, the effectiveness of targeted drugs was related to many factors. The effectiveness of taking targeted drugs after draining the fluid could not be determined. First of all, an important prerequisite for targeted drugs to work was that genetic testing could find sensitive gene mutation sites. If the patient's genetic test results showed that there was a suitable target, the targeted drug could be effective. There was no direct causality between the operation of draining the fluid from late-stage lung cancer and the effectiveness of the targeted drug. Secondly, the duration of the targeted drug's effect on the patient also varied from person to person. Some patients may see obvious effects at the beginning of the drug, such as tumor shrinking, but due to the possible resistance of cancer cells, the effect may change over time. Some patients may have a good effect at first, but after a period of time (the specific length of time may vary from several months to several years), due to the adaptability of the cancer cells (such as replacing the cell pathway inhibited by the targeted drug through other pathways), the treatment effect will not be ideal. In addition, different types of lung cancer had different responses to targeted drugs. For example, the molecular characteristics of lung cancer were that even if genetic testing was done, common targets were rarely matched. In this case, the targeted drugs might not be effective. Read more exciting novels for free
How long will it take for targeted drugs to be effective for lung cancer?
Patients with lung cancer usually took targeted drugs for ten days, no more than forty days, and the effect would take effect in two to three days. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is it always effective to take targeted drugs for lung cancer?
The effect of targeted drugs on lung cancer patients was not very good. Target drugs could not cure lung cancer. Although they could prolong survival time, they could not always be effective. There were very few driver mutations in lung cancer, so there were relatively few targeted drugs that could be used. When using targeted drugs, it was necessary to find the target of lung cancer and could not be used blindly. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
How long do you take targeted drugs for lung cancer?
The time taken for targeted treatment of lung cancer needed to be considered from both the patient's own condition and the progression of the disease. For patients with middle-stage lung cancer, it is recommended to take the first-generation targeted drug for 1.5 - 2 years or the third-generation targeted drug for 3 years. For patients with advanced lung cancer, as long as the targeted drug was effective, it was recommended to take it until the disease progressed. If drug resistance appeared, the targeted drug would need to be replaced. However, it should be noted that the premise of using targeted drugs was that the patient must have a clear target for treatment in the body, and there must be a specific drug targeting the target before targeted drug therapy could be carried out. Less than 20% of lung cancer patients could find targeted drugs. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is an 85-year-old man's late-stage lung cancer targeted drug effective?
Advanced lung cancer could be treated with targeted therapy, which was a very important method in the treatment of lung cancer. However, targeted therapy required a specific target. It was a precise treatment method. The appropriate targeted drug had to be selected according to the different pathological types of lung cancer and the different gene mutation characteristics. For an 85-year-old patient with advanced lung cancer, if there was a suitable target, the targeted drug was effective. For example, in patients with lung cancer with advanced egfr-mutation, the effective rate of oral egfr-small-molecular Tyrosin Kinase Inhibition targeted drugs could reach 70%. The efficacy was better than chemotherapy and the side effects were significantly lower than chemotherapy. Most patients could tolerate it, even in elderly patients. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the effects of taking targeted drugs in the late stage of liver cancer?
There may be the following symptoms when taking targeted drugs for late-stage liver cancer: - If the condition was under control and the tumor growth was suppressed, the tumor might shrink. - For patients with late-stage liver cancer who developed ascitic fluid, if their stomachs gradually subsided after taking the targeted drug, it might mean that the ascitic fluid decreased and the condition was controlled to a certain extent. - The patient's condition was stable. For example, although the tumor did not shrink after taking the targeted drug, its growth rate slowed down. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Late stage liver cancer, taking targeted drugs, black stool discharge
There may be many reasons for black stool discharge in patients with late-stage liver cancer when taking targeted drugs. The following is the specific analysis and countermeasures: ##1. Reason Analysis 1. ** Drug factor ** - The targeted drug may cause bleeding in the digestive tract. The hemoglobinin the blood will turn black after digestion in the intestine, resulting in black feces. 2. ** Disease-related factors ** - Patients with late-stage liver cancer may have coagulated due to tumor invasion of the liver, which may lead to digestive tract bleeding. In addition, bleeding from the ruptured esophagus and gastric varices caused by portal vein hypertention was also a common cause. 3. ** Dietary factors ** - Although it is rare, eating too much black food recently (such as mulberries, animal blood products, etc.) may also cause the color of the stool to turn black. ##2. Treatment 1. ** See a doctor immediately ** - After black stool appears, the patient should immediately seek medical attention and describe the symptoms and medication to the doctor in detail. 2. ** Complete relevant checks ** - The doctor may arrange for a stool occult blood test, a colonoscopy, and other examinations to determine if there is any bleeding in the digestive tract and its cause. 3. ** Adjusts treatment plan ** - According to the results of the examination, the doctor may adjust the dose of the targeted drug or change the drug to reduce the risk of digestive tract bleeding. 4. ** Bleeding control treatment ** - If a diagnosis of digestive tract bleeding was confirmed, the doctor might give hemostatic drugs (such as vitamins K1, tranexamic acid, etc.) to promote the synthesis of blood clot factors and reduce bleeding. 5. ** Protect gastric mucus ** - The damaged liver function of patients with late-stage liver cancer may affect the secretion and secretion of bile, causing bile to flow back into the stomach and cause damage to the gastric mucus. At this time, you can use a protective agent for the digestive tract (such as aluminum magnesite, sucralfate, etc.) to neutralize gastric acid and protect the gastric mucus. 6. ** Nutritional support ** - Patients with late-stage liver cancer were usually in poor physical condition, and nutritional supplements (such as compound aa, fat milk, etc.) could provide the necessary nutrients to support the patient's recovery process. 7. ** Pay attention to rest ** - The patient should pay attention to rest and avoid overwork to avoid increasing the burden on the liver. In short, the blackness of patients with late-stage liver cancer during targeted drug therapy was a symptom that needed to be taken seriously. Patients should pay close attention to the changes in their symptoms. If they have persistent black stool or other discomfort symptoms, they should inform the doctor in time. At the same time, they should maintain good eating habits, avoid eating food that may increase the burden on the stomach and intestines, and follow the doctor's advice for treatment and adjustment. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What is the survival rate of targeted drugs in the treatment of advanced lung cancer?
There was a large individual difference in the survival rate of patients with advanced lung cancer after taking targeted drugs. The time from the start of treatment to disease progression or death was 9.2 - 18.9 months, and the general overall survival period was 21.6 - 36 months. Some studies had shown that the average survival time for late-stage lung cancer patients with targeted drugs was about three years, but there were also cases where it was as short as one or two years and as long as ten years. According to the data, after comprehensive treatment, the 2-year survival rate of stage IUA lung cancer patients was 23%, the 5-year survival rate was 10%, and the medium survival time was 11.5 months. For stage IUA lung cancer patients who had multiple metastasies, the 2-year survival rate was 10%, and the medium survival time was 6 months. In addition, in some studies, the 1-year, 2-year, 3-year, 4-year, and 5-year overall survival rates of the control group (first-line therapy with a combination of a combination The patient's physical condition, the effect of the targeted therapy, whether the attitude was positive, the degree of cooperation with the treatment, whether the patient had underlying diseases, and the support, care, and financial investment of the family would all affect the survival rate. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is it useful to take targeted drugs for esophagus cancer metastasizing?
At present, a variety of targeted drugs were available for the treatment of esophagus cancer, including new small molecules multi-target Tyrosin Kinase Inhibition, drugs that targeted HEL2, cetuxed that targeted the egFr target, and bevacizumb that targeted the veg-like growth factor target, etc. There was also a combination of PD1 - 1 inhibition and targeted HEL2 for the treatment of cancer at the gastric-esophagus junction. Chinese studies have shown that as a new small-molecular multi-target Tyrosinase Kinase Inhibition, anlotinib and apitini have a certain effect in the treatment of esophagus cancer. The combination therapy of trastuzumab-targeted to HEL2 and PD1 inhibition drugs (such as pembrolizumab) combined with chemotherapy can be used as the first-line treatment for cancer of the gastroesophagus junction, advanced gastric cancer with HEL2 positive, and esophagus cancer. In the second-line treatment of China guidelines for the treatment of esophagus cancer, level II recommendations were given to anlotinib (Class 2A) and apitini (Class 3). However, there were no phase III clinical trials to prove that molecular targeted drugs could prolong the survival of patients with esophagus cancer. The effect of targeted therapy needed further study. In general, molecular targeted therapy had a certain clinical value for the treatment of patients with esophagus cancer, including those with metastasizing, but it still needed further in-depth research. These drugs must be used under the guidance of a professional doctor. It is not recommended for patients to buy and take them themselves to avoid serious adverse reactions. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Late stage lung cancer, vomiting black water
The reason why patients with late-stage lung cancer vomited black water could be caused by many factors, including non-pathological factors and pathological factors. Non-pathological factors may be related to diet and drugs. For example, eating less or insufficient food intake leads to hypoproteinuria, which causes water in gastric juice to seep out into the tissue space to form ascitic fluid, compressing the stomach and affecting normal swallowing function. Eating dark-colored food or taking drugs that contain coloring may also cause symptoms of vomiting black water. Pathological factors may include digestive tract bleeding, such as esophagus and gastric variceal bleeding, cardiac tearing syndrome, digestive tract bleeding, lung infection, tumor necrotic factor release, etc. However, the specific situation varied from person to person. It was necessary to judge whether it was normal according to the patient's condition and physique. It was recommended to see a doctor in time and carry out relevant examinations to determine the cause of the disease and carry out corresponding treatment.
Late stage lung cancer vomiting black water
It may be normal for patients with advanced lung cancer to vomit black water, or it may be related to digestive tract bleeding. When cancer cells spread in patients with late-stage lung cancer, the digestive tract may be damaged, leading to vomiting and vomiting black water. This situation was normal and did not require special treatment. However, if a patient with late-stage lung cancer was accompanied by other discomfort symptoms in addition to vomiting black water, such as severe abdominal pain, hematemesis, etc., it might be caused by digestive tract bleeding. The reasons for vomiting black water in patients with advanced lung cancer may also include food, drugs, respiratory tract infection, digestive system diseases, cardiovascular diseases, or tumor-related diseases. The patient was advised to seek medical treatment in time, undergo relevant examinations, and make a clear diagnosis. Comprehensive treatment was given according to the doctor's guidance to delay the progression of the disease and improve the quality of life.